The results demonstrated that upregulation of PTPRCAP expression in lung adenocarcinoma A549 cells significantly inhibited the protein levels of Bcl-2 compared with the vector groups, but the expression level of BAX and Caspase-3 increased (P < 0.05, n = 3, Fig 8A). The gene discussed is BCL2; the disease is lung adenocarcinoma.